查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球Peptone市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按原产地类型、按产品、按应用、按最终用户、按地区
市场调查报告书
商品编码
1413765

全球Peptone市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按原产地类型、按产品、按应用、按最终用户、按地区

Peptone Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 335 Pages | 商品交期: 2-5个工作天内

价格
简介目录

目前，全球Peptone市场规模为 1.5 亿美元，预计将以 5% 的复合年增长率成长，到 2031 年将达到 2.05 亿美元。这一增长是由骨科疾病患病率上升和临床数位化需求不断增加等因素所推动的。2024年，动物源性Peptone在全球市场占据主导地位，占据50%以上的市场。此外，Peptone在全球细胞培养基市场中也扮演着重要角色。

领先的生物製药製造商正在采用外包模式来扩大市场范围并提高获利能力。与当地供应商的长期合作伙伴关係可以降低营运成本并提高定价。透过利用亚太资源并与当地合约製造商合作，企业可以实现永续成长。

亚洲、中东和非洲的政府当局正在积极鼓励医疗保健和生物製药产业的发展。投资诱因等有利的政府政策正在为企业投资Peptone市场创造重要机会。

使用动物性Peptone进行细胞培养优化会带来病毒污染的风险，进而影响培养基品质。复杂的监管审批流程可能会减慢Peptone的分配。公司通常必须等待所有监管部门的批准才能将更新或改进的产品推向市场，阻碍了成长。

该报告研究了全球Peptone市场，并提供了市场概述，包括按来源类型、产品、应用、最终用户、区域划分的趋势以及进入市场的公司的竞争趋势。

目录

第一章执行摘要

第二章市场概况

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • COVID-19 影响分析
  • 乌克兰与俄罗斯衝突的影响
  • 经济概况
  • PESTLE分析

第三章 2018-2031年全球Peptone市场展望

  • 2018-2031 年全球Peptone市场前景（按产地类型、价值（百万美元））
  • 2018-2031 年全球Peptone市场前景（按产品、价值（百万美元））
  • 2018-2031 年全球Peptone市场前景（按应用、价值（百万美元））
  • 全球Peptone市场展望，按最终用户划分，价值（百万美元），2018-2031
  • 全球Peptone市场展望，按地区，价值（百万美元），2018-2031

第四章 2018-2031年北美Peptone市场展望

第五章 2018-2031年欧洲Peptone市场展望

第六章 2018-2031 年亚太地区Peptone市场展望

第七章 2018-2031 年拉丁美洲Peptone市场展望

第八章 2018-2031 年中东与非洲Peptone市场展望

第9章 竞争格局

  • 动脉类型和适应症热图
  • 製造商和指示热图
  • 2023 年公司市场份额分析
  • 比赛仪表板
  • 公司简介
    • Hi-Media Laboratories
    • B. Braun Melsungen AG

第10章附录

简介目录

The global Peptone market is currently valued at US$ 150 million and is set to expand at an impressive compound annual growth rate (CAGR) of 5%, projecting a market valuation of US$ 205 million by the year 2031. This growth is driven by factors such as the rising prevalence of orthopedic diseases and the increasing demand for clinical digitization. Peptones, derived from animal sources, dominated the global market in 2024, accounting for over 50% of the market share. Furthermore, peptones played a vital role in the global cell culture media market.

Opportunities for Peptone Manufacturers:

Several opportunities are on the horizon for peptone manufacturers:

  • Contract Manufacturing in Asia Pacific: Leading biopharmaceutical players are embracing outsourcing models to expand their market reach and enhance their profitability. Long-term partnerships with local suppliers can lower operational costs and improve pricing. By capitalizing on resources in Asia Pacific and forming partnerships with local contract-based manufacturers, companies can achieve sustainable growth.
  • Government Support for Biopharmaceutical Industry: Government authorities in Asian and Middle Eastern & African countries are actively encouraging healthcare and biopharmaceutical industry growth. Favorable government policies, such as investment incentives, are creating significant opportunities for companies to invest in the peptone market.

Challenges Affecting Peptone Demand:

Despite the promising outlook, the peptone market faces challenges:

  • Risk of Virus Contamination During Cell Culture: The use of animal-derived peptones in cell culture optimization poses a risk of viral contamination, potentially affecting the quality of the media.
  • Regulatory Approval Complexity: The complex regulatory approval process can delay peptone distribution. Companies often need to wait for all regulatory approvals before introducing updated or improved products to the market, hindering growth.

Country-wise Insights:

How are Peptone Suppliers Strategizing in the U.S. Market?

"Expansion & Increasing Production Capacity by U.S. Companies"

The U.S. dominates the North American peptone market, holding a substantial market share.

The prevalence of life-threatening chronic diseases in the U.S. has driven its market leadership in North America. Leading players in the industry are expanding production capacity and improving their manufacturing processes, offering growth opportunities. For example, Nu-Tek BioSciences, LLC introduced the first animal-free peptone and protein hydrolysate manufacturing facility in Austin, U.S., in March 2021.

Why is the Peptone Industry Significant in Germany?

"Presence of Leading Peptone Manufacturers"

Germany holds a significant share in the European peptone market, thanks to its strong healthcare expenditure.

Germany boasts a substantial healthcare expenditure and is expected to maintain steady growth. The presence of major industry players in the country ensures the availability of peptone products, contributing to its significant market share.

Why is China Emerging as a Noteworthy Market for Peptones?

"Strategic Initiatives by Industry Players in China"

In 2023, China's peptone market held a considerable market share in East Asia.

China is actively developing its healthcare infrastructure and pursuing strategic collaborations for expansion. The presence of numerous importers, exporters, and collaborative research activities augments the growth of the peptone market in China. Furthermore, China's exports of active pharmaceutical ingredients are expected to boost the demand for peptones.

What is the Outlook for the India Peptone Market?

"Rapid Growth of the Biotechnology Industry and Research Activities"

India dominates the South Asia peptone market, with a substantial market share in 2023.

India's biotechnology sector is experiencing rapid growth, with a flourishing research environment. The country is home to thousands of biotech businesses, including core companies and startups. The biotechnology market in India is projected to continue expanding, driven by research activities.

Competitive Landscape:

Leading peptone suppliers are actively engaged in collaborative approaches, mergers, and acquisitions to expand their market presence and drive research and development efforts. Companies such as Hi-Media Laboratories, Thermo Fisher Scientific, Inc., and Merck KGaA are focused on product launches, acquisitions, and approvals to enhance their market position.

Key Companies Driving Innovation:

  • Hi-Media Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Hardy Diagnostics
  • Solabia Group
  • Kerry Inc.
  • Organotechnie
  • Biotecnica
  • Nu-Tek BioScience LLC
  • Tatua
  • Krishna Enzytech Pvt. Ltd.
  • Titan Biotech
  • Suvidhinath Laboratories
  • Jeevan Biotech

Key Segments Covered in Peptone Industry Survey

Peptone Market by Source:

  • Plants

Soya Peptones

Vegetable Peptones

Others

  • Yeast

Peptone

Extract

  • Animal

Beef Extract

Casein Peptones

Gelatin Peptones

Brain Heart Infusion (Bovine)

Brain Heart Infusion (Porcine)

Casein (Acid Hydrolysate)

Heart Infusion (Bovine)

Heart Infusion (Porcine)

Lactalbumin

Meat Peptone (Bovine)

Meat Peptone (Porcine)

Ox-Bile

Peptonized Milk

Polypeptone

Pork Heart Digest

Protease Peptones

Peptone Market by Product:

  • Protein Hydrolysates
  • Infusions
  • Extracts

Peptone Market by Application:

  • Microbial Cell Culture
  • Mammalian Cell Culture
  • Plant Tissue Culture
  • Yeast Culture

Peptone Market by End User:

  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • Contract Research Laboratories

Peptone Market by Region:

  • North America Peptone Market
  • Latin America Peptone Market
  • Europe Peptone Market
  • South Asia Peptone Market
  • East Asia Peptone Market
  • Oceania Peptone Market
  • The Middle East & Africa (MEA) Peptone Market

Table of Contents

1. Executive Summary

  • 1.1. Global Peptone Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Peptone Market Outlook, 2018 - 2031

  • 3.1. Global Peptone Market Outlook, by Source Type, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Plants
        • 3.1.1.1.1. Soya Peptones
        • 3.1.1.1.2. Vegetable Peptones
        • 3.1.1.1.3. Others
      • 3.1.1.2. Yeast
        • 3.1.1.2.1. Peptone
        • 3.1.1.2.2. Extract
      • 3.1.1.3. Animal
        • 3.1.1.3.1. Beef Extract
        • 3.1.1.3.2. Casein Peptones
        • 3.1.1.3.3. Gelatin Peptones
        • 3.1.1.3.4. Brain Heart Infusion (Bovine)
        • 3.1.1.3.5. Brain Heart Infusion (Porcine)
        • 3.1.1.3.6. Casein (Acid Hydrolysate)
        • 3.1.1.3.7. Heart Infusion (Bovine)
        • 3.1.1.3.8. Heart Infusion (Porcine)
        • 3.1.1.3.9. Lactalbumin
        • 3.1.1.3.10. Meat Peptone (Bovine)
        • 3.1.1.3.11. Meat Peptone (Porcine)
        • 3.1.1.3.12. Ox-Bile
        • 3.1.1.3.13. Peptonized Milk
        • 3.1.1.3.14. Polypeptone
        • 3.1.1.3.15. Pork Heart Digest
        • 3.1.1.3.16. Protease Peptones
  • 3.2. Global Peptone Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Protein Hydrolysates
      • 3.2.1.2. Infusions
      • 3.2.1.3. Extracts
  • 3.3. Global Peptone Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Microbial Cell Culture
      • 3.3.1.2. Mammalian Cell Culture
      • 3.3.1.3. Plant Tissue Culture
      • 3.3.1.4. Yeast Culture
  • 3.4. Global Peptone Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Academic & Research Institutes
      • 3.4.1.2. Biopharmaceutical Companies
      • 3.4.1.3. Contract Research Laboratories
  • 3.5. Global Peptone Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Peptone Market Outlook, 2018 - 2031

  • 4.1. North America Peptone Market Outlook, by Source Type, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Plants
        • 4.1.1.1.1. Soya Peptones
        • 4.1.1.1.2. Vegetable Peptones
        • 4.1.1.1.3. Others
      • 4.1.1.2. Yeast
        • 4.1.1.2.1. Peptone
        • 4.1.1.2.2. Extract
      • 4.1.1.3. Animal
        • 4.1.1.3.1. Beef Extract
        • 4.1.1.3.2. Casein Peptones
        • 4.1.1.3.3. Gelatin Peptones
        • 4.1.1.3.4. Brain Heart Infusion (Bovine)
        • 4.1.1.3.5. Brain Heart Infusion (Porcine)
        • 4.1.1.3.6. Casein (Acid Hydrolysate)
        • 4.1.1.3.7. Heart Infusion (Bovine)
        • 4.1.1.3.8. Heart Infusion (Porcine)
        • 4.1.1.3.9. Lactalbumin
        • 4.1.1.3.10. Meat Peptone (Bovine)
        • 4.1.1.3.11. Meat Peptone (Porcine)
        • 4.1.1.3.12. Ox-Bile
        • 4.1.1.3.13. Peptonized Milk
        • 4.1.1.3.14. Polypeptone
        • 4.1.1.3.15. Pork Heart Digest
        • 4.1.1.3.16. Protease Peptones
  • 4.2. North America Peptone Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Protein Hydrolysates
      • 4.2.1.2. Infusions
      • 4.2.1.3. Extracts
  • 4.3. North America Peptone Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Microbial Cell Culture
      • 4.3.1.2. Mammalian Cell Culture
      • 4.3.1.3. Plant Tissue Culture
      • 4.3.1.4. Yeast Culture
  • 4.4. North America Peptone Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Academic & Research Institutes
      • 4.4.1.2. Biopharmaceutical Companies
      • 4.4.1.3. Contract Research Laboratories
  • 4.5. North America Peptone Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.2. U.S. Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 4.5.1.3. U.S. Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.4. U.S. Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 4.5.1.5. Canada Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.6. Canada Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 4.5.1.7. Canada Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.8. Canada Peptone Market End User, Value (US$ Mn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Peptone Market Outlook, 2018 - 2031

  • 5.1. Europe Peptone Market Outlook, by Source Type, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Plants
        • 5.1.1.1.1. Soya Peptones
        • 5.1.1.1.2. Vegetable Peptones
        • 5.1.1.1.3. Others
      • 5.1.1.2. Yeast
        • 5.1.1.2.1. Peptone
        • 5.1.1.2.2. Extract
      • 5.1.1.3. Animal
        • 5.1.1.3.1. Beef Extract
        • 5.1.1.3.2. Casein Peptones
        • 5.1.1.3.3. Gelatin Peptones
        • 5.1.1.3.4. Brain Heart Infusion (Bovine)
        • 5.1.1.3.5. Brain Heart Infusion (Porcine)
        • 5.1.1.3.6. Casein (Acid Hydrolysate)
        • 5.1.1.3.7. Heart Infusion (Bovine)
        • 5.1.1.3.8. Heart Infusion (Porcine)
        • 5.1.1.3.9. Lactalbumin
        • 5.1.1.3.10. Meat Peptone (Bovine)
        • 5.1.1.3.11. Meat Peptone (Porcine)
        • 5.1.1.3.12. Ox-Bile
        • 5.1.1.3.13. Peptonized Milk
        • 5.1.1.3.14. Polypeptone
        • 5.1.1.3.15. Pork Heart Digest
        • 5.1.1.3.16. Protease Peptones
  • 5.2. Europe Peptone Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Protein Hydrolysates
      • 5.2.1.2. Infusions
      • 5.2.1.3. Extracts
  • 5.3. Europe Peptone Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Microbial Cell Culture
      • 5.3.1.2. Mammalian Cell Culture
      • 5.3.1.3. Plant Tissue Culture
      • 5.3.1.4. Yeast Culture
  • 5.4. Europe Peptone Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Academic & Research Institutes
      • 5.4.1.2. Biopharmaceutical Companies
      • 5.4.1.3. Contract Research Laboratories
  • 5.5. Europe Peptone Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.2. Germany Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 5.5.1.3. Germany Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.4. Germany Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.5. U.K. Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.6. U.K. Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 5.5.1.7. U.K. Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.8. U.K. Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.9. France Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.10. France Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 5.5.1.11. France Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.12. France Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.13. Italy Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.14. Italy Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 5.5.1.15. Italy Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.16. Italy Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.17. Turkey Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.18. Turkey Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 5.5.1.19. Turkey Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.20. Turkey Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.21. Russia Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.22. Russia Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 5.5.1.23. Russia Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.24. Russia Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Peptone Market End User, Value (US$ Mn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Peptone Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Peptone Market Outlook, by Source Type, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Plants
        • 6.1.1.1.1. Soya Peptones
        • 6.1.1.1.2. Vegetable Peptones
        • 6.1.1.1.3. Others
      • 6.1.1.2. Yeast
        • 6.1.1.2.1. Peptone
        • 6.1.1.2.2. Extract
      • 6.1.1.3. Animal
        • 6.1.1.3.1. Beef Extract
        • 6.1.1.3.2. Casein Peptones
        • 6.1.1.3.3. Gelatin Peptones
        • 6.1.1.3.4. Brain Heart Infusion (Bovine)
        • 6.1.1.3.5. Brain Heart Infusion (Porcine)
        • 6.1.1.3.6. Casein (Acid Hydrolysate)
        • 6.1.1.3.7. Heart Infusion (Bovine)
        • 6.1.1.3.8. Heart Infusion (Porcine)
        • 6.1.1.3.9. Lactalbumin
        • 6.1.1.3.10. Meat Peptone (Bovine)
        • 6.1.1.3.11. Meat Peptone (Porcine)
        • 6.1.1.3.12. Ox-Bile
        • 6.1.1.3.13. Peptonized Milk
        • 6.1.1.3.14. Polypeptone
        • 6.1.1.3.15. Pork Heart Digest
        • 6.1.1.3.16. Protease Peptones
  • 6.2. Asia Pacific Peptone Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Protein Hydrolysates
      • 6.2.1.2. Infusions
      • 6.2.1.3. Extracts
  • 6.3. Asia Pacific Peptone Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Microbial Cell Culture
      • 6.3.1.2. Mammalian Cell Culture
      • 6.3.1.3. Plant Tissue Culture
      • 6.3.1.4. Yeast Culture
  • 6.4. Asia Pacific Peptone Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Academic & Research Institutes
      • 6.4.1.2. Biopharmaceutical Companies
      • 6.4.1.3. Contract Research Laboratories
  • 6.5. Asia Pacific Peptone Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.2. China Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 6.5.1.3. China Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.4. China Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.5. Japan Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.6. Japan Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 6.5.1.7. Japan Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.8. Japan Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.9. South Korea Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.10. South Korea Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 6.5.1.11. South Korea Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.12. South Korea Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.13. India Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.14. India Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 6.5.1.15. India Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.16. India Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Peptone Market End User, Value (US$ Mn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Peptone Market Outlook, 2018 - 2031

  • 7.1. Latin America Peptone Market Outlook, by Source Type, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Plants
        • 7.1.1.1.1. Soya Peptones
        • 7.1.1.1.2. Vegetable Peptones
        • 7.1.1.1.3. Others
      • 7.1.1.2. Yeast
        • 7.1.1.2.1. Peptone
        • 7.1.1.2.2. Extract
      • 7.1.1.3. Animal
        • 7.1.1.3.1. Beef Extract
        • 7.1.1.3.2. Casein Peptones
        • 7.1.1.3.3. Gelatin Peptones
        • 7.1.1.3.4. Brain Heart Infusion (Bovine)
        • 7.1.1.3.5. Brain Heart Infusion (Porcine)
        • 7.1.1.3.6. Casein (Acid Hydrolysate)
        • 7.1.1.3.7. Heart Infusion (Bovine)
        • 7.1.1.3.8. Heart Infusion (Porcine)
        • 7.1.1.3.9. Lactalbumin
        • 7.1.1.3.10. Meat Peptone (Bovine)
        • 7.1.1.3.11. Meat Peptone (Porcine)
        • 7.1.1.3.12. Ox-Bile
        • 7.1.1.3.13. Peptonized Milk
        • 7.1.1.3.14. Polypeptone
        • 7.1.1.3.15. Pork Heart Digest
        • 7.1.1.3.16. Protease Peptones
  • 7.2. Latin America Peptone Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Protein Hydrolysates
      • 7.2.1.2. Infusions
      • 7.2.1.3. Extracts
  • 7.3. Latin America Peptone Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Microbial Cell Culture
      • 7.3.1.2. Mammalian Cell Culture
      • 7.3.1.3. Plant Tissue Culture
      • 7.3.1.4. Yeast Culture
  • 7.4. Latin America Peptone Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Academic & Research Institutes
      • 7.4.1.2. Biopharmaceutical Companies
      • 7.4.1.3. Contract Research Laboratories
  • 7.5. Latin America Peptone Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.2. Brazil Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 7.5.1.3. Brazil Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.4. Brazil Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 7.5.1.5. Mexico Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.6. Mexico Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 7.5.1.7. Mexico Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.8. Mexico Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 7.5.1.9. Argentina Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.10. Argentina Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 7.5.1.11. Argentina Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.12. Argentina Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Peptone Market End User, Value (US$ Mn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Peptone Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Peptone Market Outlook, by Source Type, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Plants
        • 8.1.1.1.1. Soya Peptones
        • 8.1.1.1.2. Vegetable Peptones
        • 8.1.1.1.3. Others
      • 8.1.1.2. Yeast
        • 8.1.1.2.1. Peptone
        • 8.1.1.2.2. Extract
      • 8.1.1.3. Animal
        • 8.1.1.3.1. Beef Extract
        • 8.1.1.3.2. Casein Peptones
        • 8.1.1.3.3. Gelatin Peptones
        • 8.1.1.3.4. Brain Heart Infusion (Bovine)
        • 8.1.1.3.5. Brain Heart Infusion (Porcine)
        • 8.1.1.3.6. Casein (Acid Hydrolysate)
        • 8.1.1.3.7. Heart Infusion (Bovine)
        • 8.1.1.3.8. Heart Infusion (Porcine)
        • 8.1.1.3.9. Lactalbumin
        • 8.1.1.3.10. Meat Peptone (Bovine)
        • 8.1.1.3.11. Meat Peptone (Porcine)
        • 8.1.1.3.12. Ox-Bile
        • 8.1.1.3.13. Peptonized Milk
        • 8.1.1.3.14. Polypeptone
        • 8.1.1.3.15. Pork Heart Digest
        • 8.1.1.3.16. Protease Peptones
  • 8.2. Middle East & Africa Peptone Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Protein Hydrolysates
      • 8.2.1.2. Infusions
      • 8.2.1.3. Extracts
  • 8.3. Middle East & Africa Peptone Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Microbial Cell Culture
      • 8.3.1.2. Mammalian Cell Culture
      • 8.3.1.3. Plant Tissue Culture
      • 8.3.1.4. Yeast Culture
  • 8.4. Middle East & Africa Peptone Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Academic & Research Institutes
      • 8.4.1.2. Biopharmaceutical Companies
      • 8.4.1.3. Contract Research Laboratories
  • 8.5. Middle East & Africa Peptone Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.2. GCC Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 8.5.1.3. GCC Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.4. GCC Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.5. South Africa Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.6. South Africa Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 8.5.1.7. South Africa Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.8. South Africa Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.9. Egypt Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.10. Egypt Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 8.5.1.11. Egypt Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.12. Egypt Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.13. Nigeria Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.14. Nigeria Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 8.5.1.15. Nigeria Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.16. Nigeria Peptone Market End User, Value (US$ Mn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Peptone Market Indication, Value (US$ Mn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Peptone Market End User, Value (US$ Mn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Artery Type vs Indication Heatmap
  • 9.2. Manufacturer vs Indication Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Hi-Media Laboratories
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Hi-Media Laboratories
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Hi-Media Laboratories
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Hi-Media Laboratories
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Hi-Media Laboratories
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Hi-Media Laboratories
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. B. Braun Melsungen AG
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Hi-Media Laboratories
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Hi-Media Laboratories
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Hi-Media Laboratories
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Hi-Media Laboratories
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Hi-Media Laboratories
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Hi-Media Laboratories
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Hi-Media Laboratories
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations